We found a significant upregulation (11.3-fold higher) of NFKB1 in severe COVID-19 patients (7.73 [0.86-47.18]) compared to the control group (0.68 [0.20-1.89]), P = 0.0001. The gene discussed is NFKB1; the disease is COVID-19.